91
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Effect of PVP K30 and/or l-Arginine on Stability Constant of Etoricoxib–HPβCD Inclusion Complex: Preparation and Characterization of Etoricoxib–HPβCD Binary System

, , , &
Pages 118-129 | Published online: 01 Jan 2009
 

Abstract

The effect of polyvinyl pyrrolidone (PVP) K30 and/or l-arginine on etoricoxib–HPβCD complex was investigated. The phase solubility profiles were classified as AL-type, both in absence or presence of auxiliary substances used. The apparent stability constant (Kc) of binary complex obtained at room temperature, 371.80 ± 2.61 M−1, was decreased with the addition of PVP and arginine indicating no benefit of addition of auxiliary substances to promote higher complexation efficiency. Therefore, solid etoricoxib–HPβCD binary systems were prepared and characterized by proton nuclear magnetic resonance spectroscopy (1HNMR), X-ray powder diffractometry, Fourier transformation-infrared spectroscopy, and dissolution studies. Among all binary systems, a lyophilized product showed superior performance in enhancing dissolution of etoricoxib.

ACKNOWLEDGMENTS

The authors are thankful to Shivaji University, Kolhapur, Maharashtra, India for providing XRD facility and to Pune University, Pune, Maharashtra, India for providing FTIR, and NMR facilities, respectively. The authors are very much thankful to Principal, Government College of Pharmacy, Karad, Maharashtra, India for providing laboratory facilities and constant encouragement.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.